Gene News and Research

Latest Gene News and Research

Tβ4 may help treat skeletal muscle disease in Duchenne muscular dystrophy

REGENERX BIOPHARMACEUTICALS, INC. announced today that a research team in Washington, D.C. has found that dystrophin-deficient Mdx mice, treated twice a week for six months with Tβ4, showed a significant increase in skeletal muscle regenerating fibers compared to untreated mice. No effects related to muscle function or fibrosis and no adverse reactions were observed in the mice.

6 Feb 2010

Breakthrough research could lead to new potential treatments for malaria

Groundbreaking research done at Singapore's Nanyang Technological University's (NTU) School of Biological Sciences (SBS) could lead to the development of more potent drugs or a vaccine for malaria, which is transmitted to humans by infected mosquitoes and kills up to three million people each year.

6 Feb 2010

Breakthrough discovery could help in developing a broad spectrum of antiviral drugs

Within a virus's tiny exterior is a store of energy waiting to be unleashed. When the virus encounters a host cell, this pent-up energy is released, propelling the viral DNA into the cell and turning it into a virus factory.

6 Feb 2010

BIO urges HHS to preserve incentives for investment and innovation; improve patient access to genetic tests

The Biotechnology Industry Organization (BIO) released today a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests.

6 Feb 2010

Scientists employ new approach to understand metabolic changes of TB bacteria

The complex chain of metabolic events in bacteria that lead to fatal diseases such as tuberculosis (TB) may be better understood using mathematical models, according to an article published in the February issue of Microbiology Today.

5 Feb 2010

Biotechnology: The next medical revolution

A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease.

5 Feb 2010

EVMS researchers identify source that causes Type 1 diabetes

Doctors at Eastern Virginia Medical School's Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

5 Feb 2010

Results validating performance of GSN’s proprietary Parental Support technology published

Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).

5 Feb 2010

Anti-doping community urges researchers and athletes to fight illegal doping

With the 2010 Winter Olympic Games just days away, officials in the anti-doping community are urging researchers and those in the athletic community to re-double their efforts to fight illegal doping.

5 Feb 2010

International Stem Cell opens new cell production facility in Oceanside, California

International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners’ clinical-grade stem cell products.

5 Feb 2010

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart’s MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient’s own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

5 Feb 2010

Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five

Children who were exposed to acetaminophen prenatally were more likely to have asthma symptoms at age five in a study of 300 African-American and Dominican Republic children living in New York City.

5 Feb 2010

Around seven in every thousand morbidly obese people are missing part of their DNA

A small but significant proportion of morbidly obese people are missing a section of their DNA, according to research published today in Nature. The authors of the study, from Imperial College London and ten other European Centres, say that missing DNA such as that identified in this research may be having a dramatic effect on some people's weight.

4 Feb 2010

Defective chromosome cause of severe obesity

A new cause of obesity due to a defect on chromosome 16 has just been discovered. It is thought to explain close to 1% of obesity cases. For carriers of the defect, the risk of becoming overweight is 50 times higher. This research is the result of close cooperation between the team of Professor Froguel, a CNRS researcher, in Lille, and colleagues at Imperial College in London and Vaudois University Hospital in Lausanne, with the support of ten other European research groups. The findings of the study are to be published in Nature on February 4, 2010.

4 Feb 2010

Genes of mother and fetus linked to risk of preterm labor and birth

New evidence that genetics play a significant role in some premature births may help explain why a woman can do everything right and still give birth too soon.

4 Feb 2010

Health Discovery receives final patent infringement payment from Vermillion

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc.

4 Feb 2010

DNA variants in mother and fetus can increase risk of preterm labor

Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery.

4 Feb 2010

Study could lead to non-surgical alternatives for tonsillectomies

Children with obstructive sleep apnea (OSA) may one day be able to have an injection or use a throat spray instead of getting their tonsils removed to cure their snoring, according to a new study from the University of Chicago, which found that a specific gene product may be responsible for the proliferation of adenotonsillar tissue that can cause pediatric OSA.

4 Feb 2010

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

A research team led by Dr. John D. Rioux, a researcher at the Montreal Heart Institute (MHI) and professor in the faculty of medicine at the Université de Montréal, has been awarded a grant of more than $2.3 million to finance a major research project on the integrative biology of inflammatory diseases. From among the roughly 70 applications submitted, Dr. Rioux's team is one of six selected by the Canadian Institutes of Health Research to receive the Emerging Team Grant - From Genes to Proteins, Cells, Tissues and Patients.

4 Feb 2010

Court weighs patents for human genes

The American Civil Liberties Union has sued a genetics company that holds patents on breast- and ovarian-cancer-causing genes, saying their claims on the two genes hinders further research by other companies and scientists, the Associated Press/CBS News reports.

4 Feb 2010

Gene News and Research

Latest Gene News and Research

Tβ4 may help treat skeletal muscle disease in Duchenne muscular dystrophy

Breakthrough research could lead to new potential treatments for malaria

Breakthrough discovery could help in developing a broad spectrum of antiviral drugs

BIO urges HHS to preserve incentives for investment and innovation; improve patient access to genetic tests

Scientists employ new approach to understand metabolic changes of TB bacteria

Biotechnology: The next medical revolution

EVMS researchers identify source that causes Type 1 diabetes

Results validating performance of GSN’s proprietary Parental Support technology published

Anti-doping community urges researchers and athletes to fight illegal doping

International Stem Cell opens new cell production facility in Oceanside, California

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five

Around seven in every thousand morbidly obese people are missing part of their DNA

Defective chromosome cause of severe obesity

Genes of mother and fetus linked to risk of preterm labor and birth

Health Discovery receives final patent infringement payment from Vermillion

DNA variants in mother and fetus can increase risk of preterm labor

Study could lead to non-surgical alternatives for tonsillectomies

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

Court weighs patents for human genes

eBook: Using iPSCs models for human disease research and drug discovery eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS